Nurses’ and Medical Doctors’ Perception and Management Status on Ototoxicity Related to Chemotherapy
10.5388/aon.2022.22.2.111
- Author:
Jung Hyo YU
1
;
Siyeon KIM
;
Moon Hee KANG
Author Information
1. Advanced Practice Nurse, Department of Nursing, Chungnam National University Hospital, Daejeon, Korea
- Publication Type:Original Article
- From:Asian Oncology Nursing
2022;22(2):111-120
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:The purpose of this study was to investigate the perception of ototoxicity related to chemotherapy (cisplatin) and management status among nurses and doctors.
Methods:The participating subjects were 247 nurses working in the oncology ward and the anti-cancer injection room and 40 internal medicine doctors in C University Hospital of D City. The data were collected from October to November 2019, using a self-report structured questionnaire and analyzed by the SPSS/WIN 24.0 program.
Results:As a result of this study, 51.4% of nurses answered that they had knowledge of ototoxicity, 33.5% provided prior information on ototoxicity, and 4.5% provided information on the hearing test before cisplatin administration. The group with knowledge of cisplatin-related ototoxicity provided more information on both ototoxicity (χ²=105.02, p<.001) and hearing test (χ²=5.27, p=.022) than the group without knowledge of ototoxicity. The provision of education, including the contents of ototoxicity, improved the nurses’ knowledge about cisplatin-related ototoxicity, and it was found that more information about hearing loss was provided.
Conclusion:It was confirmed that education on the symptoms of cisplatin-related ototoxicity was required and no ototoxicity management system was in place. Therefore, it is necessary to develop an ototoxicity management program at the hospital level, which will have an effect on improving nursing practice for cancer patients.
